About
I am a creative and dynamic Medical Doctor, former Assistant Professor in clinical…
Articles by Thomas
-
First time in Davos, where important people come to become unimportant (unless they have to be invited to parties)
First time in Davos, where important people come to become unimportant (unless they have to be invited to parties)
By Thomas Clozel
-
What I am learning (1): leadership is a complicated concept!
What I am learning (1): leadership is a complicated concept!
By Thomas Clozel
Activity
-
People would often ask me what it’s like to be working at Nabla. One of the things I love most about Nabla is the deep trust that runs through the…
People would often ask me what it’s like to be working at Nabla. One of the things I love most about Nabla is the deep trust that runs through the…
Liked by Thomas Clozel
-
When we announced our #MOSAIC initiative last year at ASCO, I never thought we would have come so far only a year later: it already is the world’s…
When we announced our #MOSAIC initiative last year at ASCO, I never thought we would have come so far only a year later: it already is the world’s…
Liked by Thomas Clozel
-
Great opportunity for an experienced Chem Tox specialist to come join our computational drug design department. This will be a highly visible and…
Great opportunity for an experienced Chem Tox specialist to come join our computational drug design department. This will be a highly visible and…
Liked by Thomas Clozel
Experience
Education
Volunteer Experience
Publications
-
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma
Cancer Discovery
The problem of chemoresistant DLBCL remains the most urgent challenge in the clinical management of patients with this disease. We describe a mechanism-based approach toward the rational translation of DNMTIs for the treatment of high-risk DLBCL.
Other authorsSee publication
Languages
-
French
Native or bilingual proficiency
-
English
Full professional proficiency
-
German
Elementary proficiency
More activity by Thomas
-
Bridging the gap from lab to real-world market for transformative impact since 2015. Thrilled to announce that Breega led the €8.5M seed round of…
Bridging the gap from lab to real-world market for transformative impact since 2015. Thrilled to announce that Breega led the €8.5M seed round of…
Liked by Thomas Clozel
-
🇪🇸Ola ola - ESMO - European Society for Medical Oncology is around the corner - we cannot be more excited to announce a MAJOR milestone the world’s…
🇪🇸Ola ola - ESMO - European Society for Medical Oncology is around the corner - we cannot be more excited to announce a MAJOR milestone the world’s…
Shared by Thomas Clozel
-
𝗡𝗼𝘂𝘃𝗲𝗹𝗹𝗲 𝘁𝗿𝗶𝗯𝘂𝗻𝗲 𝗱𝗮𝗻𝘀 𝗟𝗲 𝗙𝗶𝗴𝗮𝗿𝗼 À l’heure où nos existences se tissent autant dans le réel que dans le virtuel, les États…
𝗡𝗼𝘂𝘃𝗲𝗹𝗹𝗲 𝘁𝗿𝗶𝗯𝘂𝗻𝗲 𝗱𝗮𝗻𝘀 𝗟𝗲 𝗙𝗶𝗴𝗮𝗿𝗼 À l’heure où nos existences se tissent autant dans le réel que dans le virtuel, les États…
Liked by Thomas Clozel
-
ESMO - European Society for Medical Oncology is around the corner! Join us as we share insights from the world’s largest spatial multi-omics atlas…
ESMO - European Society for Medical Oncology is around the corner! Join us as we share insights from the world’s largest spatial multi-omics atlas…
Liked by Thomas Clozel
-
𝗖𝗔𝗡𝗔𝗟 sort en 2025 une série documentaire sur le FC Versailles en 6 épisodes de 40 minutes 💥 J'ai été bercé par le "vivons heureux, vivons…
𝗖𝗔𝗡𝗔𝗟 sort en 2025 une série documentaire sur le FC Versailles en 6 épisodes de 40 minutes 💥 J'ai été bercé par le "vivons heureux, vivons…
Liked by Thomas Clozel
-
Quality of integration, onboarding and motivation at 3 months for a new employee is truly a surrogate marker of success at 5 years. Early signs of…
Quality of integration, onboarding and motivation at 3 months for a new employee is truly a surrogate marker of success at 5 years. Early signs of…
Posted by Thomas Clozel
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More